Cytokinetics Inc. buy JPMorgan Chase & Co.
Start price
09.06.25
/
50%
€29.00
Target price
09.06.26
€46.41
Performance (%)
101.52%
End price
10.06.26
€58.44
Summary
This prediction ended on 10.06.26 with a price of €58.44. With a performance of 101.52% the BUY prediction by JPMorgan_Chase___Co_ was a big success. JPMorgan_Chase___Co_ has a follow-up prediction for Cytokinetics Inc. where he still thinks Cytokinetics Inc. is a Buy. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Cytokinetics Inc. | -10.031% | -10.031% | 101.519% |
| iShares Core DAX® | 0.881% | 5.632% | 8.477% |
| iShares Nasdaq 100 | 2.390% | 1.571% | 28.412% |
| iShares Nikkei 225® | 4.269% | 2.521% | 50.984% |
| iShares S&P 500 | 1.171% | 2.545% | 23.603% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics, Incorporated (NASDAQ: CYTK) had its price target lowered by analysts at JPMorgan Chase & Co. from $71.00 to $53.00. They now have an "overweight" rating on the stock.
Ratings data for CYTK provided by MarketBeat
In the thread Trading Cytokinetics Inc.
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by JPMorgan_Chase___Co_ for Cytokinetics Inc.
Stopped prediction by JPMorgan_Chase___Co_ for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€50.50
05.09.24
05.09.24
€63.96
05.09.25
05.09.25
-9.31%
06.09.25
06.09.25
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€49.60
24.06.24
24.06.24
€60.52
24.06.25
24.06.25
-42.74%
25.06.25
25.06.25